25 April 2026

PBAC says yes to tirzepatide for T2D – but Lilly says no

7 minute read

Diabetes Pharmaceuticals

By

Amanda Sheppeard

A pricing stalemate between the pharma company and the government means the former is calling time on its PBS application.

This content is for AHPRA registered professionals only.
Login Join Now

End of content

No more pages to load

Register ×

Register for a new account

Email Address

Password

Confirm Password

First Name

Last Name

Full Name LEAVE THIS BLANK

What field do you work in?

Type of University work:

Industry Specialty:

Other:

Billing Address

First Name

Last Name

Address 1

Address 2

City

State

Postal Code

Country

Phone

Payment Information We Accept Visa, Mastercard, American Express, and Discover

Card Number

Expiration Date /

Security Code (CVC) (what's this?)

I agree to the Terms and conditions and privacy policy *

Processing...